SK13596A3 - 15,15-dialkyl-substituted derivatives of estradiol, preparation method of these compounds, intermediates of this method and a pharmaceutical composition - Google Patents
15,15-dialkyl-substituted derivatives of estradiol, preparation method of these compounds, intermediates of this method and a pharmaceutical composition Download PDFInfo
- Publication number
- SK13596A3 SK13596A3 SK135-96A SK13596A SK13596A3 SK 13596 A3 SK13596 A3 SK 13596A3 SK 13596 A SK13596 A SK 13596A SK 13596 A3 SK13596 A3 SK 13596A3
- Authority
- SK
- Slovakia
- Prior art keywords
- compound
- carbon atoms
- group
- dialkyl
- alkyl group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Silver Salt Photography Or Processing Solution Therefor (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4326240A DE4326240A1 (de) | 1993-08-02 | 1993-08-02 | 15,15-Dialkyl-substituierte Derivate des Estradiols |
| PCT/EP1994/002540 WO1995004070A1 (en) | 1993-08-02 | 1994-08-01 | 15,15-dialkyl-substituted derivatives of estradiol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK13596A3 true SK13596A3 (en) | 1997-03-05 |
Family
ID=6494482
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK135-96A SK13596A3 (en) | 1993-08-02 | 1994-08-01 | 15,15-dialkyl-substituted derivatives of estradiol, preparation method of these compounds, intermediates of this method and a pharmaceutical composition |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US5587496A (zh) |
| EP (1) | EP0712412B1 (zh) |
| JP (1) | JPH09500891A (zh) |
| KR (1) | KR960703940A (zh) |
| CN (1) | CN1040329C (zh) |
| AT (1) | ATE175418T1 (zh) |
| AU (1) | AU674609B2 (zh) |
| CA (1) | CA2168657A1 (zh) |
| CZ (1) | CZ26796A3 (zh) |
| DE (2) | DE4326240A1 (zh) |
| FI (1) | FI960465A0 (zh) |
| HU (1) | HUT73238A (zh) |
| IL (1) | IL110530A (zh) |
| MY (1) | MY111121A (zh) |
| NO (1) | NO960425L (zh) |
| NZ (1) | NZ271091A (zh) |
| PL (1) | PL312792A1 (zh) |
| RU (1) | RU2147306C1 (zh) |
| SK (1) | SK13596A3 (zh) |
| WO (1) | WO1995004070A1 (zh) |
| ZA (1) | ZA945754B (zh) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4326240A1 (de) * | 1993-08-02 | 1995-02-09 | Schering Ag | 15,15-Dialkyl-substituierte Derivate des Estradiols |
| DE4447401A1 (de) | 1994-12-23 | 1996-07-04 | Schering Ag | 14,17-C¶2¶-überbrückte Steroide |
| DE19906159A1 (de) * | 1999-02-09 | 2000-08-10 | Schering Ag | 16-Hydroxyestratriene als selektiv wirksame Estrogene |
| DE10151365A1 (de) * | 2001-10-17 | 2003-04-30 | Schering Ag | 17-Chlor-D-Homosteroide als selektive Estrogenrezeptorantagonisten |
| WO2005087194A1 (en) * | 2004-03-10 | 2005-09-22 | Schering Aktiengesellschaft | Compositions comprising drospirenone molecularly dispersed |
| MY142989A (en) * | 2004-03-10 | 2011-02-14 | Bayer Schering Pharma Ag | Stabilised supersaturated solids of lipophilic drugs |
| US20050220825A1 (en) * | 2004-03-10 | 2005-10-06 | Adrian Funke | Molecular dispersions of drospirenone |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2275752A (en) * | 1938-11-25 | 1942-03-10 | Ciba Pharm Prod Inc | Cyclic condensation products and process of making same |
| US3472881A (en) * | 1965-05-14 | 1969-10-14 | Merck & Co Inc | 3 - hydroxy - 13 - lower alkyl - 15 - carboxyl - 1,3,5(10),8,14 - gonapentaen - 17-ones and intermediates in the production thereof |
| US3766224A (en) * | 1971-06-03 | 1973-10-16 | Sandoz Ag | 15-methyl-substituted steroids |
| DD145919B1 (de) * | 1978-06-28 | 1982-06-30 | Kurt Ponsold | Verfahren zur herstellung von 14,1 -methylenderivaten der oestranreihe |
| DE3628189A1 (de) * | 1986-08-20 | 1988-02-25 | Schering Ag | Oestrogen wirksame mittel und 14,17ss-ethano-14ss-estratriene |
| DE4326240A1 (de) * | 1993-08-02 | 1995-02-09 | Schering Ag | 15,15-Dialkyl-substituierte Derivate des Estradiols |
-
1993
- 1993-08-02 DE DE4326240A patent/DE4326240A1/de not_active Withdrawn
-
1994
- 1994-08-01 RU RU96105421A patent/RU2147306C1/ru active
- 1994-08-01 SK SK135-96A patent/SK13596A3/sk unknown
- 1994-08-01 PL PL94312792A patent/PL312792A1/xx unknown
- 1994-08-01 CA CA002168657A patent/CA2168657A1/en not_active Abandoned
- 1994-08-01 NZ NZ271091A patent/NZ271091A/en unknown
- 1994-08-01 DE DE69415812T patent/DE69415812T2/de not_active Expired - Lifetime
- 1994-08-01 HU HU9600234A patent/HUT73238A/hu unknown
- 1994-08-01 JP JP7505581A patent/JPH09500891A/ja not_active Ceased
- 1994-08-01 CZ CZ96267A patent/CZ26796A3/cs unknown
- 1994-08-01 WO PCT/EP1994/002540 patent/WO1995004070A1/en not_active Application Discontinuation
- 1994-08-01 CN CN94192968A patent/CN1040329C/zh not_active Expired - Fee Related
- 1994-08-01 KR KR1019960700521A patent/KR960703940A/ko not_active Application Discontinuation
- 1994-08-01 AU AU74610/94A patent/AU674609B2/en not_active Ceased
- 1994-08-01 EP EP94924304A patent/EP0712412B1/en not_active Expired - Lifetime
- 1994-08-01 IL IL11053094A patent/IL110530A/en not_active IP Right Cessation
- 1994-08-01 AT AT94924304T patent/ATE175418T1/de not_active IP Right Cessation
- 1994-08-02 ZA ZA945754A patent/ZA945754B/xx unknown
- 1994-08-02 MY MYPI94002013A patent/MY111121A/en unknown
- 1994-08-02 US US08/284,786 patent/US5587496A/en not_active Expired - Fee Related
-
1995
- 1995-06-07 US US08/472,722 patent/US5656622A/en not_active Expired - Fee Related
-
1996
- 1996-02-01 NO NO960425A patent/NO960425L/no unknown
- 1996-02-01 FI FI960465A patent/FI960465A0/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL110530A0 (en) | 1994-11-11 |
| RU2147306C1 (ru) | 2000-04-10 |
| DE4326240A1 (de) | 1995-02-09 |
| JPH09500891A (ja) | 1997-01-28 |
| CN1040329C (zh) | 1998-10-21 |
| IL110530A (en) | 1998-08-16 |
| CA2168657A1 (en) | 1995-02-09 |
| NZ271091A (en) | 1996-08-27 |
| CZ26796A3 (en) | 1996-07-17 |
| US5587496A (en) | 1996-12-24 |
| NO960425D0 (no) | 1996-02-01 |
| EP0712412B1 (en) | 1999-01-07 |
| CN1128031A (zh) | 1996-07-31 |
| NO960425L (no) | 1996-04-02 |
| HUT73238A (en) | 1996-07-29 |
| AU7461094A (en) | 1995-02-28 |
| ZA945754B (en) | 1995-03-15 |
| FI960465A (fi) | 1996-02-01 |
| DE69415812T2 (de) | 1999-09-16 |
| US5656622A (en) | 1997-08-12 |
| MY111121A (en) | 1999-08-30 |
| AU674609B2 (en) | 1997-01-02 |
| PL312792A1 (en) | 1996-05-13 |
| ATE175418T1 (de) | 1999-01-15 |
| KR960703940A (ko) | 1996-08-31 |
| WO1995004070A1 (en) | 1995-02-09 |
| EP0712412A1 (en) | 1996-05-22 |
| FI960465A0 (fi) | 1996-02-01 |
| DE69415812D1 (de) | 1999-03-18 |
| HU9600234D0 (en) | 1996-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20040029847A1 (en) | 8Beta-substituted-11-beta-pentyl-and 11-beta-hexyl-estra-1,3,5(10)-triene derivatives | |
| JP2003505394A (ja) | 経口活性アンドロゲン | |
| SK13596A3 (en) | 15,15-dialkyl-substituted derivatives of estradiol, preparation method of these compounds, intermediates of this method and a pharmaceutical composition | |
| US20040198711A1 (en) | 15Alpha-substituted estradiol carboxylic acid esters as locally active estrogens | |
| JPH0515720B2 (zh) | ||
| EP1212345B1 (en) | Orally active 7-alpha-alkyl androgens | |
| FI102902B (fi) | Menetelmä terapeuttisesti käyttökelpoisten 14 ,17 -silloitettujen es tratrieenien valmistamiseksi | |
| US20040059140A1 (en) | 14(15)-unsaturated 15- and/or 16-substituted androgens with mixed androgen-progrestational profile | |
| US5418227A (en) | 14,16β-ethano-15β, 16(1)-cyclo-14β-estra-1,3,5(10)-trienes | |
| JP4279552B2 (ja) | 新規アンドロゲンとしてのメチレンステロイド | |
| US5439902A (en) | 14α, 16α-ethanoand 14α, 16α-etheno-estratrienes |